Aikido Pharma has composed a drug portfolio that
Aikido Pharma has composed a drug portfolio that focuses on the treatment of four cancers, prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). For more information, visit us online or call us at 212-745-1373.
-
Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics